THE APEX TIMES
Curative exits a major Salesforce CRM contract, rolling out an in-house AI CRM for healthcare operations
In a deal that outlines intensifying pressure on big enterprise CRM vendors, Curative said it is ending a major Salesforce relationship and replacing it with an internal, AI-powered customer relationship management system built to move faster and reduce costs for healthcare operations.
Curative, a healthcare-focused organization, said it is ending a major contract for customer relationship management software from Salesforce, according to a report published by Yahoo Finance on Aug. 11, 2026. The company is instead rolling out its own in-house CRM platform designed specifically for its operations, with an emphasis on using AI to support day-to-day healthcare workflows.
The report frames the shift as a tradeoff between outsourcing CRM capabilities to a large vendor versus keeping the system internal. Curative cited cost and speed advantages from its internal platform compared with the previous Salesforce arrangement, describing the move as a way to accelerate implementation and reduce spending.
CRM systems are software used by organizations to manage interactions with customers and partners, track information and communications, and coordinate processes across teams. For healthcare organizations, CRM-like workflows often overlap with patient-facing or partner-facing coordination, scheduling, inquiry handling, and internal reporting, even when the organization’s core technology stack includes other specialized platforms.
While the report indicates that Curative is deploying an AI-powered in-house CRM, it does not provide full implementation details, such as the timeline for rollout, whether the system is limited to specific departments, or how broadly it will replace Salesforce functions. It also does not clarify the size of the Salesforce contract that is being ended, nor whether any other Salesforce products beyond CRM were involved in the decision.
Salesforce’s customer relationship management suite is one of its best-known products, and the broader Salesforce ecosystem is widely used by enterprises to unify sales, service, marketing, and other customer operations under one platform. In practice, transitions away from a major Salesforce CRM agreement can be operationally complex because companies often need to migrate data, retrain users, and rebuild integrations with other systems.
Curative’s stated rationale also highlights a broader industry tension: enterprise software buyers increasingly evaluate internal AI-enabled systems against vendor platforms on metrics like time to deploy, customization, and ongoing costs. As AI capabilities become more embedded across enterprise tools, organizations may seek architectures that they can adjust quickly, particularly when requirements are specialized and change frequently.
Even so, the information publicly available in the cited report is not enough to determine what functionality Curative preserved, what it re-engineered, or how performance will be measured after the transition. It is also unclear whether Curative’s in-house CRM is developed entirely in-house, built with partners, or supported by specific third-party AI components.
What to watch next is whether Curative provides additional disclosures about the rollout scope and the operational outcomes it expects from its in-house AI CRM. For Salesforce, the key question is whether this will remain an isolated customer decision or becomes part of a larger pattern of CRM migrations as healthcare and other sectors benchmark vendor costs and deployment speed against internal alternatives.
Why It Matters
- A healthcare organization shifting away from a major Salesforce CRM relationship underscores how strongly buyers weigh total cost and deployment speed in enterprise software decisions.
- If Curative’s in-house approach proves faster or cheaper in practice, it could increase competitive pressure on large CRM platforms to demonstrate quicker implementation and clearer cost advantages.
- For Salesforce, customer exits can affect perceptions around retention, especially if buyers conclude that vendor CRM systems cannot match the flexibility of tailored internal AI systems.
- The absence of disclosed migration and performance metrics makes near-term impact difficult to quantify, but it indicates a potentially meaningful adoption direction in AI-enabled customer operations.
Key Facts
- Curative ended a major Salesforce CRM-related contract, according to a Yahoo Finance report dated Aug. 11, 2026.
- Curative is rolling out an in-house CRM platform that it describes as AI-powered.
- Curative cited cost and speed advantages as reasons for moving away from Salesforce.
- The report does not disclose detailed contract size, rollout timeline, or which Salesforce products beyond CRM were involved.
- CRM systems are used to manage customer and partner interactions, information, and process coordination across teams, including healthcare-adjacent workflows.
Technology Related
Intel’s push toward on-prem, privacy-focused AI gets a partnership spotlight as Xeon 6 platform work expands
A new extension to Kasm Technologies’ deal work with Intel highlights a market trend toward running large language model workloads locally on enterprise hardware, aiming to reduce data exposure and reliance on GPUs.
Broadcom (AVGO) set to report earnings Wednesday after the bell, with investors focused on guidance and demand outlines
The fabless chip and software maker Broadcom will release its next quarterly results this Wednesday after market close, according to a preview posted by Yahoo Finance.
Apple’s John Ternus steps in as investors weigh a valuation-driven “nearly $5 trillion” challenge
A leadership handoff arrives after a sharp stock rally and with Apple trading at a high forward-earnings multiple, narrowing the margin for error, according to market commentary.
Salesforce shares jump 22% after results challenge AI skepticism, CNBC’s Jim Cramer says
Salesforce reported fiscal second-quarter 2027 results on Aug. 27, sending its stock up about 22.6% as investors reassessed worries that artificial intelligence would undercut demand for enterprise software. Jim Cramer, speaking in a market context reported by Yahoo Finance, argued those AI fears were overblown.
Seasonality on Wall Street turns investors’ attention to September, with Nvidia and Micron in focus
A widely cited market pattern says the Nasdaq has fallen in 48% of Septembers since 1971, reigniting questions about whether the calendar has any edge for high-growth technology stocks.
Jim Cramer argues Netflix’s valuation should reflect durability despite leadership shake-up
On CNBC’s Mad Money, the host addressed a viewer question about whether to hold or adjust a position in Netflix after recent company leadership moves and setbacks.
Netflix releases a new trailer and key art for ‘The Fixers,’ previewing covert missions in Taiwan’s temple world
The streamer says the latest promotional materials offer a deeper look at embedded operatives and a hidden network tied to traditional temple culture in Taiwan.
Nvidia’s $3.5 Billion Push Highlights a Broader AI Supply-Chain Strategy
A report says Nvidia is backing the next phase of AI expansion with a $3.5 billion commitment tied to its push across cloud, custom silicon, edge computing, and automotive systems.
Anthropic signs a $35 billion cloud computing deal tied to Nvidia-backed startup
The AI lab says it has secured access to large-scale computing capacity through a U.S. startup that is backed by Nvidia, adding to a broader wave of infrastructure contracts as model developers race to secure enough GPU time.
Amazon shares drop after FTC lawsuit alleges manipulation of advertising prices
Amazon.com Inc. (AMZN) fell following a U.S. Federal Trade Commission lawsuit that accuses the company of using tactics on its ad marketplace to control advertising pricing and extract significant value from advertisers.
